Episodes

  • A Community Health Worker (CHW) is a frontline public health worker who is a trusted member of the community they serve. CHWs act as a bridge between health and social services and the community, helping to improve health outcomes and access to care.

    Our goal during this episode is to discuss why training pharmacy technicians to step into the role of a Community Health Worker has been imperative to meeting the health equity demands in local communities.

    Jen Moulton, BSPharm
    President
    CEimpact

    Meredith Ayers, CPhT-Adv, CHW
    Development Specialist
    Bremo Pharmacy

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Evaluate the role and impact of pharmacy-placed Community Health Workers (CHWs) on patient outcomes and community health.
    2. Describe a plan to integrate CHWs into pharmacy practice by cross-training pharmacy technicians.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-260-H04-P
    Initial release date: 9/9/2024
    Expiration date: 9/9/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.

    The GameChanger
    The new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.


    Guests
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Amanda Bushman, PharmD, BCPS-AQ ID, BCIDP, FIDSA
    Infectious Disease Pharmacist
    UnityPoint Health

    Tony Mannum, PharmD
    PGY2 Infectious Disease Resident
    UnityPoint Health
    Reference

    IDSA Guidelines for treating resistant gram negative organisms

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.
    2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-251-H01-P
    Initial release date: 09/02/2024
    Expiration date: 09/02/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Missing episodes?

    Click here to refresh the feed.

  • The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.

    The GameChanger
    New guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice.

    Guest
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Matthew Trump, DO, FACP, FCCP
    Pulmonologist
    The Iowa Clinic

    Reference
    Guidelines
    Paper

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.
    2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-247-H01-P
    Initial release date: 08/26/2024
    Expiration date: 08/26/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Stigmatizing language may be part of our daily interactions with patients without even realizing it. It can appear in charts, regardless of race, gender, gender identity, ability, or socioeconomic status, but it has been found to occur more frequently for groups who are traditionally marginalized. How often do you reflect on the language you use with patients and how it might be interpreted by them, depending on their unique circumstances? And what are we doing as preceptors to help our residents and students understand the importance of language in their patient interactions? Listen in to learn more.

    Host
    Kathy Schott, PhD
    Vice President, Education & Operations
    CEimpact

    Guest
    Kashelle Lockman, PharmD, MA
    Clinical Associate Professor
    University of Iowa

    Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

    CPE Information

    Learning Objectives
    At the end of this course, preceptors will be able to:
    1. List examples of stigmatizing language and its impact on pharmacist-patient interactions
    2. Describe strategies preceptors can use to foster the use of non-stigmatizing language by students and residents

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-250-H99-P
    Initial release date: 8/21/2024
    Expiration date: 8/21/2027
    Additional CPE details can be found here.

    The speakers have no relevant financial relationships with ineligible companies to disclose.

    This program has been:
    Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

    Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay it's onset.

    The GameChanger
    Several studies suggest a delay in onset of dementia with the recombinant shingles vaccine.

    Guest
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    The recombinant shingles vaccine is associated with lower risk of dementia

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Describe dementia's epidemiology and the significance of preventive interventions.
    2. Discuss the strengths, weaknesses, and outcomes of the study.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-246-H01-P
    Initial release date: 08/19/2024
    Expiration date: 08/19/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings.

    The GameChanger
    Adopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management.

    Guests
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Jake Galdo, PharmD, MBA, BCPS, BCGP
    CEO
    Seguridad


    Reference
    Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations

    Previous GameChangers on PREVENT score

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.
    2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.



    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-245-H01-P
    Initial release date: 08/12/2024
    Expiration date: 08/12/2025
    Additional CPE details can be found here.


    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • The power of physical fitness in managing diabetes is transforming patient care. Join us this week as we discuss how pharmacists can significantly enhance patient outcomes by integrating exercise education into their practice, alongside traditional medication management.

    The GameChanger
    Incorporating brief but impactful conversations about the importance of physical fitness into patient consultations can significantly enhance diabetes management.

    Guests
    Mark Smith, Jr., PharmD, CDCES, AFAA-CGFI
    Pharmacist
    UAB Medicine

    Ian Haywood, PharmD, BCPS, CDCES
    Clinical Pharmacist
    Baptist Memorial Hospital



    Reference Materials
    The Role of Exercise in Diabetes
    Physical Activity and Diabetes Position from the ADA

    Supplemental Continuing Education Courses
    Glucose Whisperers: The Role of CGMs in Pharmacy Practice - 1hr
    Guardians of the Glucose Galaxy: The Rise of CGMs - 1hr
    Pharmacy and Continuous Glucose Monitoring: The Sweetest Pairing - 6.5hrs

    Additional GameChangers Episodes
    Continuous Glucose Monitors

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the impact of physical fitness on diabetes management.
    2. Identify strategies for educating patients on exercise and diabetes.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-224-H01-P
    Initial release date: 08/05/2024
    Expiration date: 08/05/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.

    The GameChanger
    Several new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss.

    Guests
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Jake Galdo, PharmD, MBA, BCPS, BCGP
    CEO
    Seguridad

    References
    Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

    Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity


    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.
    2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-238-H01-P
    Initial release date: 07/29/2024
    Expiration date: 07/29/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • 1 out of 3 adult Americans take a daily multivitamin. On this episode of GameChangers, we discuss a recent study which examined whether daily multivitamin use extends life or prevents common causes of death.

    The GameChanger
    The study found no evidence that daily multivitamin use reduced death from common conditions such as heart disease or cancer.

    Guest
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Jake Galdo, PharmD, MBA, BCPS, BCGP
    CEO, Seguridad


    References
    Multi-Vitamin Study
    NIH Press Release

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the use of multivitamins.
    2. Identify implications for healthy patients considering multivitamin use.



    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-226-H01-P
    Initial release date: 07/22/2024
    Expiration date: 07/22/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • While health inequity is considered by many to be the #1 issue in healthcare today, we’re still just learning to talk about it as part of pharmacy education. As preceptors, health equity and social determinants of health may not have been a language we learned as part of our education, and yet we rely on preceptors to help develop our learners in this area. What is our role in incorporating conversations and education around health equity and social determinants of health to better educate our learners in improving the lives of patients?

    Host
    Kathy Schott, PhD
    Vice President, Education & Operations
    CEimpact

    Guest
    Sally Arif, PharmD, BCCP
    Professor of Pharmacy Practice/Clinical Cardiology Pharmacist
    Midwestern University College of Pharmacy
    Rush Medical Center
    Chicago, IL

    Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

    CPE Information

    Learning Objectives
    At the end of this course, preceptors will be able to:
    1. Discuss a preceptor's role in educating student pharmacists and pharmacy residents about social determinants of health
    2. Describe strategies preceptors can use to incorporate social determinants of health into their teaching

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-210-H99-P
    Initial release date: 7/17/2024
    Expiration date: 7/17/2027
    Additional CPE details can be found here.

    The speakers have no relevant financial relationships with ineligible companies to disclose.

    This program has been:
    Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

    Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • In this week's episode, we dive into the fascinating world of gut health, including three actionable tips you can provide to patients. Explore the critical role of gut microbiome in health conditions ranging from autoimmune disorders to mental health to skin conditions.

    The GameChanger
    Health outcomes can be significantly impacted by addressing gut health issues through dietary modifications, understanding drug-nutrient depletions, and promoting the use of probiotics and prebiotics.

    Guest
    Anna Garrett, PharmD, BCPS
    President, AnnaGarrett.com

    Reference
    How Gut Health Affects Your Whole Body

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the relationship between gut health and systemic conditions.
    2. Identify strategies for assessing and addressing gut health issues, including dietary modifications, the use of probiotics and prebiotics, and the identification of drug-nutrient depletions.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-221-H01-P
    Initial release date: 07/15/2024
    Expiration date: 07/15/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • On this week's GameChangers episode, we discuss prevention of recurrent UTIs, including whether use of d-mannose or antibiotics are effective.

    The GameChanger
    Recurrent urinary tract infections plague some women throughout their lives. There are ways to prevent recurrent UTIs, however a recent study determined that d-mannose is not effective. We discuss what is effective.

    Guest
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women
    A Randomized Clinical Trial

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Describe non-pharmacologic strategies proven to decrease recurrent UTIs.
    2. Discuss selection of an antibiotic and a selected patient for continuous prophylaxis.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-220-H01-P
    Initial release date: 07/08/2024
    Expiration date: 07/08/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • In this week's episode of GameChangers, we focus on how pharmacists can prevent weight-based dosing errors.

    Listen in to learn more about:

    Which body weights to use for which medication-based dosingThe four different scales of weight“Normal” weights for kidsThe Rule of 5 for dosing pediatric patientsWhat the formula is for switching from pediatric dosing to adult dosingThe definition of “Patient first language”


    The GameChanger
    Too often, health care providers don't dose medications based on weight. The pharmacist should be ensuring doses are correct based on patient weight.

    Guests

    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Jake Galdo, PharmD, MBA, BCPS, BCGP
    CEO
    Seguridad

    Stephanie Weightman, PharmD, BCPS, BCPPS, BCEMP
    Clinical Pharmacy Manager
    Perfecting Peds


    Reference
    Pediatric Weight is Crucial to Perfecting the Dose
    Updated antimicrobial dosing recommendations for obese patients

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss strategies to verify weight-based dosing accuracy to improve patient safety and therapeutic outcomes.
    2. Explain appropriate dosing adjustments for commonly prescribed antibiotics in pediatric patients and patients with obesity.


    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-208-H01-P
    Initial release date: 06/24/2024
    Expiration date: 06/24/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Today's episode is an absolute must-listen to. The FDA's decision to approve the drug, Mifepristone, has been escalated in a lawsuit to the U.S. Supreme Court. And, last week, in a unanimous 9-0 decision, the U.S. Supreme Court rejected the challenge to the drug's approval. Today on our podcast, we are answering what exactly is happening with the drug Mifepristone, the legal challenges associated with this medication, and how this U.S. Supreme Court ruling directly impacts pharmacists today.

    Regardless of your position on this topic, knowing and understanding the history and why the mifepristone conversation is happening is critical.

    By the time you finish listening, you'll be inspired to take immediate action to join your local and state-level pharmacy association.

    For more resources, including links to the discussions, education, and training mentioned in the episode, click here to learn more.



    The GameChanger
    Pharmacists should understand legal boundaries and ethical considerations surrounding medications like mifepristone to provide safe, compliant, and patient-centered care.

    Guest
    David Brushwood, RPh, JD
    Senior Lecturer
    University of Wyoming

    Reference
    Supreme Court Document on Ruling
    Supreme Court preserves access to abortion pill

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Describe the historical context and legal evolution of mifepristone regulation by the FDA, including key changes and their implications for pharmacy practice.

    2. Identify the ethical responsibilities and state and federal legal requirements when dispensing medications such as mifepristone.



    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-209-H03-P
    Initial release date: 06/24/2024
    Expiration date: 06/24/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Can compassion and empathy be learned? Can it be taught? The evidence suggests that the answer to both of these questions is yes, and yet as preceptors, we interact with student pharmacists and pharmacy residents who are wide-ranging in their abilities and comfort-level when it comes to fostering impactful patient care interactions.

    In this episode, explore the value (and challenges) of incorporating strategies that model and teach empathy and compassion - for your patients, your learners, and for you.

    Host
    Kathy Schott, PhD
    Vice President, Education & Operations
    CEimpact

    Guest
    Kate Cozart, Med, PharmD, BCPS, BCGP, BCACP
    Clinical Pharmacist Practitioner, Primary Care
    Residency Program Coordinator
    VA Tennessee Valley Healthcare System (TVHS)
    Clarksville, TN

    Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

    CPE Information

    Learning Objectives
    At the end of this course, preceptors will be able to:
    1. Review evidence that compassionate and empathetic patient care positively impacts patients' healthcare experience.
    2. Identify strategies preceptors can model to help pharmacy learners deliver more compassionate and empathetic care.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-191-H99-P
    Initial release date: 6/19/2024
    Expiration date: 6/19/2027
    Additional CPE details can be found here.

    The speakers have no relevant financial relationships with ineligible companies to disclose.

    This program has been:
    Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

    Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • In this week's GameChangers we explore the emerging role of colchicine in the secondary prevention of cardiovascular disease. Drs. Wall and Boyd discuss colchicine's anti-inflammatory benefits, the challenges posed by side effects and drug interactions, and the latest research shaping its future in clinical practice.

    The GameChanger
    Colchicine shows potential for secondary prevention in cardiovascular disease due to its anti-inflammatory properties, but its clinical use is limited by gastrointestinal side effects and drug interactions.



    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Mathew Boyd, PharmD
    Clinical Pharmacist, Unity Point

    Reference
    Meta-Analysis
    Clear Synergy Study

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Identify the potential benefits of colchicine in secondary prevention of cardiovascular disease based on its anti-inflammatory properties.
    2. Discuss the limitations of colchicine use in clinical practice, including gastrointestinal side effects and drug interactions.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-190-H01-P
    Initial release date: 06/17/2024
    Expiration date: 06/17/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • This week's GameChangers explores the transformative impact of continuous glucose monitors (CGMs) on diabetes care. Discover the latest advancements in CGM technology, current ADA recommendations, and practical tips for patient education.

    The GameChanger
    CGM technology is constantly changing. The devices are smaller, more user-friendly, and easier to integrate into daily life, thereby improving patient adherence and outcomes.

    Guest
    Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
    Clinical Professor and Director of Pharmacy Education
    University of South Carolina College of Pharmacy

    Reference
    ADA Info on CGMs
    AACE Guidelines Update on CGMs


    Interested in additional Diabetes and CGM pharmacy education?
    Enroll in Guardian of the Glucose Galaxy: The Rise of CGMs
    During this 1-hour CE, we will cover hot topics such as:

    The evolution of Continuous Glucose Monitors (CGMs)The impact of CGMs in improving health, clinical outcomes, and quality of life for persons with diabetesThe use of CGMs to manage diabetes across patient populationsThe role of pharmacy teams in managing people with diabetesThe opportunity to integrate CGM devices into practice

    Pharmacists Enroll Here



    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Explain the principles and applications of continuous glucose monitors (CGMs) and summarize current recommendations for their use in diabetes management.
    2. Discuss how to educate patients on CGM use, including device placement, data interpretation, and troubleshooting common issues.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-189-H01-P
    Initial release date: 06/10/2024
    Expiration date: 06/10/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • This week's GameChangers is a conversation about managing symptoms and age-related health effects through perimenopause, menopause, and post-menopause. Help patients through this time with evidence-based choices inlcuding medication, supplements, and lifestyle.

    The GameChanger
    Perimenopause is not a diagnosis, but a natural part of reproductive life which should be managed with evidence-based strategies.

    Guest
    Anna Garrett, PharmD, BCPS
    President, AnnaGarrett.com

    Reference
    Going Mad in Perimenopause? Signs and Solutions
    AARP (What Doctors Don’t Know About Menopause)
    EWG's Shopper's Guide to Pesticides in Produce
    EWG's Skin Deep
    4 Reasons Why Menopausal Women Should Lift Heavy Weights

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Differentiate between perimenopause, menopause, and post-menopause by describing the potential physiological changes.
    2. Identify common symptoms in perimenopause and evidence-based medication, supplement, and lifestyle recommendations



    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-182-H01-P
    Initial release date: 06/03/2024
    Expiration date: 06/03/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • In this week's of GameChangers Podcast, we delve into the groundbreaking reclassification of marijuana to Schedule III. We discuss impacts on the legal landscape, medical research, pharmacogenomics for CBD, and the role of healthcare providers.

    The GameChanger
    Marijuana's move to Schedule III will increase research opportunities, ease fear and stigma, and provide healthcare provider involvement in medical benefits and potential risks.

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Guest
    Marry Vuong, PharmD, BCPPS
    Clinical Pharmacy Manager
    Perfecting Peds

    Reference
    UPDATE: DEA Moves to Reschedule Cannabis from Cannabis Business Times

    NPR: Scientists welcome new rules on marijuana, but research will still face obstacles.

    CEimpact Course for Reference:
    Beyond the Haze: Pharmacist's Legal Insights on THC, CBD, and Medical Marijuana

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the reclassification of marijuana from Schedule I to Schedule III.
    2. Explain the potential benefits of the marijuana schedule change including its impact on medical research and patient access.



    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-180-H01-P
    Initial release date: 05/27/2024
    Expiration date: 05/27/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Join us as we discuss new guidelines from the American College of Gastroenterology for the management of acute pancreatitis.
    The GameChanger
    New guidelines from the ACG address changes in treatment and management of acute pancreatitis.

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    The American Journal of Gastroenterology
    Drug-Induced Acute Pancreatitis: An Evidence-Based Classification

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss changes Review the American College of Gastroenterology guidelines for the management of acute pancreatitis.
    2. Discuss changes in treatment of acute pancreatitis.



    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-175-H01-P
    Initial release date: 05/20/2024
    Expiration date: 05/20/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram